NGFR

NGFR

NGFR Overview

Molecule Name
Low affinity neurotrophin receptor p75NTR
Synonyms
tumor necrosis factor receptor superfamily member 16; CD271; Gp80-LNGFR; member 16 nerve growth factor receptor; p75 ICD; p75 NTR
Drug Development Progress
Drugs in Clinical Trials3
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
Gp80-LNGFR,P75NTR,CD271 Antigen,Low-Affinity Nerve Growth Factor Receptor,Tumor Necrosis Factor Receptor Superfamily Member 16,Low Affinity Nerve Growth Factor Receptor,Low Affinity Neurotrophin Receptor P75NTR,Nerve Growth Factor Receptor (TNFR Superfamily, Member 16),TNFR Superfamily, Member 16,Nerve Growth Factor Receptor,P75 ICD,P75(NTR),TNFRSF16,CD271
Background
The p75 neurotrophin receptor (p75NTR) was originally identified as a low-affinity receptor for neurotrophins(NGF R).p75NTR is a neurotrophic factor receptor. Neurotrophic factor receptors bind Neurotrophins including Nerve growth factor, Neurotrophin-3, Brain-derived neurotrophic factor, and Neurotrophin-4. All neurotrophins bind to p75NTR. This also includes the immature pro-neurotrophin forms. Neurotrophic factor receptors, including p75NTR, are responsible for ensuring a proper density to target ratio of developing neurons, refining broader maps in development into precise connections. p75NTR is involved in pathways that promote neuronal survival and neuronal death.

NGFR Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
LM11A-31LM11A-31; LM11A-31-BHSPhase 2 ClinicalPharmatrophix Inc
Alzheimer Disease; Supranuclear Palsy, Progressive
Details
Recombinant human nerve growth factor (Xintrum Pharmacouticals)rh-NGF; ZX1305; ZX-1305; ZX1305E; ZX-1305-EPhase 2 ClinicalJiangsu Zhongxin Pharmaceutical Co Ltd
Glaucoma, Open-Angle; Keratitis; Optic Nerve Injuries
Details
Recombinant Human Nerve Growth Factor (Kerun Biopharmaceutical)Phase 1 ClinicalChongqing Kerun Biologic Pharmaceutical Development Co Ltd
Keratitis; Xerophthalmia
Details